Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date

CSMS #46876193 - Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date U.S. Customs and Border Protection sent this bulletin at 04/05/2021 11:16 AM EDT CSMS #46876193 - Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date Due to duplication, the Food and Drug Administration (FDA) will be end-dating the Center for Drug Evaluation and Research (CDER) Product Code listed below. The product code below will be end-dated in 30 days. The end-date will be effective on May 5, 2021. End-Dated Code/Description 62G[][]58/Remicade Synonym-Infliximab Instead, please use the product code below. Product Code/Description 61Y[][]01/Infliximab Synonym-Remicade Please send any questions or concerns to the email address for the Product Code Builder Feedback: PCBFeedback@fda.hhs.gov For assistance with product code identification, the public may also refer to the FDA Product Code Builder .